Endgame Capital invests in Antler Bio, an innovative agtech company utilizing epigenetics to enhance livestock management and reduce greenhouse gas emissions.
Target Information
Antler Bio is a pioneering agtech company based in Dublin, Ireland, that is revolutionizing livestock management through the use of cutting-edge epigenetics. Their innovative approach aims to enhance the health and productivity of livestock, particularly dairy cows, in order to address the pressing challenges posed by climate change.
With the global population projected to reach 10 billion by 2050, the demand for animal protein is set to surge, primarily driven by the expanding middle class in emerging markets. While the shift towards plant-based diets and alternative proteins is underway, the adoption of such diets has been gradual. Thus, traditional animal farming will continue to play a crucial role in the global food system. Investments in solutions that significantly decrease the environmental impact of livestock farming are essential.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview
Globally, livestock farming contributes approximately 10% of total greenhouse gas emissions, with cows alone accounting for around 5 gigatons of CO₂ equiv
Similar Deals
Borski Fund, Western Development Commission → Atlantic Therapeutics
First Analysis → TPN.health
2026
Endgame Capital
invested in
Antler Bio
in
in a Other VC deal